back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-07 16:16 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$23,053
+4,301 vol $5.36 each |
127,692 | |
| Filed 2025-07-03 13:11 Tx date 2025-06-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$22,626
+4,704 vol $4.81 each |
123,391 | |
| Filed 2025-04-01 11:58 Tx date 2025-03-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$23,710
+5,211 vol $4.55 each |
118,687 | |
| Filed 2025-01-03 15:21 Tx date 2024-12-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$23,396
+6,206 vol $3.77 each |
113,476 | |
| Filed 2025-01-03 11:38 Tx date 2024-12-31 |
$EXE
Extendicare Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Rights - Deferred Share Units
56 - Grant of rights
|
+10,482 vol |
43,811 | |
| Filed 2024-12-27 10:20 Tx date 2024-12-24 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,957
+500 vol $3.91 each |
500 | |
| Filed 2024-11-14 11:41 Tx date 2024-11-14 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,655
-500 vol $3.31 each |
0 | |
| Filed 2024-10-03 09:42 Tx date 2024-09-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$22,480
+6,176 vol $3.64 each |
107,270 | |
| Filed 2024-07-05 10:14 Tx date 2024-06-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$22,025
+6,459 vol $3.41 each |
101,094 | |
| Filed 2024-04-01 13:59 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$21,808
+5,739 vol $3.80 each |
94,635 | |
| Filed 2024-03-25 13:43 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$203,114
+49,783 vol $4.08 each |
88,896 | |
| Filed 2024-01-04 16:01 Tx date 2023-12-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,819
+1,265 vol $3.81 each |
39,113 | |
| Filed 2023-12-29 21:34 Tx date 2023-12-29 |
$EXE
Extendicare Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Rights - Deferred Share Units
56 - Grant of rights
|
+12,439 vol |
33,329 | |
| Filed 2023-10-05 15:02 Tx date 2023-09-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,823
+942 vol $5.12 each |
37,848 | |
| Filed 2023-10-05 11:27 Tx date 2023-10-03 |
$CARE
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-19,167 vol |
0 | |
| Filed 2023-10-05 11:26 Tx date 2023-10-03 |
$CARE
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-99,116.90
-19,246 vol $5.15 each |
0 | |
| Filed 2023-09-03 22:15 Tx date 2023-08-29 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,575
-7,500 vol $0.61 each |
0 | |
| Filed 2023-07-05 15:34 Tx date 2023-06-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,858
+842 vol $5.77 each |
36,906 | |
| Filed 2023-06-26 12:37 Tx date 2023-06-23 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,924
+4,905 vol $0.80 each |
7,500 | |
| Filed 2023-04-04 16:24 Tx date 2023-03-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,879
+796 vol $6.13 each |
36,064 |